These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

351 related items for PubMed ID: 16797605

  • 1. Pigment epithelium-derived factor (PEDF) prevents diabetes- or advanced glycation end products (AGE)-elicited retinal leukostasis.
    Yamagishi S, Matsui T, Nakamura K, Takeuchi M, Imaizumi T.
    Microvasc Res; 2006; 72(1-2):86-90. PubMed ID: 16797605
    [Abstract] [Full Text] [Related]

  • 2. Pigment-epithelium-derived factor suppresses expression of receptor for advanced glycation end products in the eye of diabetic rats.
    Yamagishi S, Matsui T, Nakamura K, Yoshida T, Takeuchi M, Inoue H, Yoshida Y, Imaizumi T.
    Ophthalmic Res; 2007; 39(2):92-7. PubMed ID: 17284935
    [Abstract] [Full Text] [Related]

  • 3. Pigment epithelium-derived factor (PEDF) prevents platelet activation and aggregation in diabetic rats by blocking deleterious effects of advanced glycation end products (AGEs).
    Yamagishi S, Matsui T, Takenaka K, Nakamura K, Takeuchi M, Inoue H.
    Diabetes Metab Res Rev; 2009 Mar; 25(3):266-71. PubMed ID: 19165765
    [Abstract] [Full Text] [Related]

  • 4. Pigment epithelium-derived factor (PEDF) inhibits diabetes- or advanced glycation end product (AGE)-induced platelet CD40 ligand overexpression in rats.
    Yamagishi S, Matsui T, Ueda S, Takeuchi M.
    Int J Cardiol; 2010 Oct 08; 144(2):283-5. PubMed ID: 19237211
    [Abstract] [Full Text] [Related]

  • 5. Inhibition by advanced glycation end products (AGEs) of pigment epithelium-derived factor (PEDF) gene expression in microvascular endothelial cells.
    Yamagishi S, Matsui T, Inoue H.
    Drugs Exp Clin Res; 2005 Oct 08; 31(5-6):227-32. PubMed ID: 16425980
    [Abstract] [Full Text] [Related]

  • 6. Inhibition of diabetic leukostasis and blood-retinal barrier breakdown with a soluble form of a receptor for advanced glycation end products.
    Kaji Y, Usui T, Ishida S, Yamashiro K, Moore TC, Moore J, Yamamoto Y, Yamamoto H, Adamis AP.
    Invest Ophthalmol Vis Sci; 2007 Feb 08; 48(2):858-65. PubMed ID: 17251488
    [Abstract] [Full Text] [Related]

  • 7. Pigment epithelium-derived factor inhibits advanced glycation end product-elicited mesangial cell damage by blocking NF-kappaB activation.
    Ide Y, Matsui T, Ishibashi Y, Takeuchi M, Yamagishi S.
    Microvasc Res; 2010 Sep 08; 80(2):227-32. PubMed ID: 20381502
    [Abstract] [Full Text] [Related]

  • 8. Leukostasis and pigment epithelium-derived factor in rat models of diabetic retinopathy.
    Matsuoka M, Ogata N, Minamino K, Matsumura M.
    Mol Vis; 2007 Jun 29; 13():1058-65. PubMed ID: 17653050
    [Abstract] [Full Text] [Related]

  • 9. Pigment epithelium-derived factor inhibits advanced glycation end products-induced retinal vascular permeability.
    Sheikpranbabu S, Haribalaganesh R, Lee KJ, Gurunathan S.
    Biochimie; 2010 Aug 29; 92(8):1040-51. PubMed ID: 20470857
    [Abstract] [Full Text] [Related]

  • 10. Pigment epithelium-derived factor downregulates vascular endothelial growth factor (VEGF) expression and inhibits VEGF-VEGF receptor 2 binding in diabetic retinopathy.
    Zhang SX, Wang JJ, Gao G, Parke K, Ma JX.
    J Mol Endocrinol; 2006 Aug 29; 37(1):1-12. PubMed ID: 16901919
    [Abstract] [Full Text] [Related]

  • 11. Pigment epithelium-derived factor inhibits oxidative stress-induced apoptosis and dysfunction of cultured retinal pericytes.
    Amano S, Yamagishi S, Inagaki Y, Nakamura K, Takeuchi M, Inoue H, Imaizumi T.
    Microvasc Res; 2005 Jan 29; 69(1-2):45-55. PubMed ID: 15797260
    [Abstract] [Full Text] [Related]

  • 12. Phosphomannopentaose sulfate (PI-88) inhibits retinal leukostasis in diabetic rat.
    Ma P, Luo Y, Zhu X, Ma H, Hu J, Tang S.
    Biochem Biophys Res Commun; 2009 Mar 06; 380(2):402-6. PubMed ID: 19250642
    [Abstract] [Full Text] [Related]

  • 13. Advanced glycation end-products increase monocyte adhesion to retinal endothelial cells through vascular endothelial growth factor-induced ICAM-1 expression: inhibitory effect of antioxidants.
    Mamputu JC, Renier G.
    J Leukoc Biol; 2004 Jun 06; 75(6):1062-9. PubMed ID: 15020646
    [Abstract] [Full Text] [Related]

  • 14. Pigment epithelium-derived factor is a pericyte mitogen secreted by microvascular endothelial cells: possible participation of angiotensin II-elicited PEDF downregulation in diabetic retinopathy.
    Yamagishi S, Matsui T, Nakamura K, Inoue H.
    Int J Tissue React; 2005 Jun 06; 27(4):197-202. PubMed ID: 16440585
    [Abstract] [Full Text] [Related]

  • 15. Role of angiotensin II in retinal leukostasis in the diabetic rat.
    Chen P, Scicli GM, Guo M, Fenstermacher JD, Dahl D, Edwards PA, Scicli AG.
    Exp Eye Res; 2006 Nov 06; 83(5):1041-51. PubMed ID: 16822509
    [Abstract] [Full Text] [Related]

  • 16. Pigment epithelium-derived factor (PEDF) blocks angiotensin II signaling in endothelial cells via suppression of NADPH oxidase: a novel anti-oxidative mechanism of PEDF.
    Yamagishi S, Nakamura K, Ueda S, Kato S, Imaizumi T.
    Cell Tissue Res; 2005 Jun 06; 320(3):437-45. PubMed ID: 15846509
    [Abstract] [Full Text] [Related]

  • 17. Anti-inflammatory effects of pigment epithelium-derived factor in diabetic nephropathy.
    Wang JJ, Zhang SX, Mott R, Chen Y, Knapp RR, Cao W, Ma JX.
    Am J Physiol Renal Physiol; 2008 May 06; 294(5):F1166-73. PubMed ID: 18322021
    [Abstract] [Full Text] [Related]

  • 18. Pigment epithelium-derived factor inhibits advanced glycation end product-induced retinal vascular hyperpermeability by blocking reactive oxygen species-mediated vascular endothelial growth factor expression.
    Yamagishi S, Nakamura K, Matsui T, Inagaki Y, Takenaka K, Jinnouchi Y, Yoshida Y, Matsuura T, Narama I, Motomiya Y, Takeuchi M, Inoue H, Yoshimura A, Bucala R, Imaizumi T.
    J Biol Chem; 2006 Jul 21; 281(29):20213-20. PubMed ID: 16707486
    [Abstract] [Full Text] [Related]

  • 19. Effects of peroxisome proliferator-activated receptor gamma and its ligand on blood-retinal barrier in a streptozotocin-induced diabetic model.
    Muranaka K, Yanagi Y, Tamaki Y, Usui T, Kubota N, Iriyama A, Terauchi Y, Kadowaki T, Araie M.
    Invest Ophthalmol Vis Sci; 2006 Oct 21; 47(10):4547-52. PubMed ID: 17003451
    [Abstract] [Full Text] [Related]

  • 20. High levels of pigment epithelium-derived factor in the retina of a rat model of type 2 diabetes.
    Matsuoka M, Ogata N, Minamino K, Higuchi A, Matsumura M.
    Exp Eye Res; 2006 Jan 21; 82(1):172-8. PubMed ID: 16054135
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.